A trio of medical device companies that went public last year are planning follow-on offerings to raise more cash. Nevro Corp. (NYSE:NVRO), Intersect ENT (NSDQ:XENT) and Ocular Therapeutix (NSDQ:OCUL) all revealed plans for the flotations this week. Menlo Park, Calif.-based Nevro priced its 1.8-million-share offering yesterday at $51 per share, saying stockholders would put up another […]
The post Nevro, Intersect ENT, Ocular Therapeutix announce follow-on offerings appeared first on MassDevice.
from MassDevice http://ift.tt/1Idjzdw
Cap comentari:
Publica un comentari a l'entrada